Abstract Multiple myeloma (MM) is a heterogeneous disease characterized by frequent MYC translocations. Sporadic MYC activation in the germinal center of genetically engineered Vk*MYC mice is sufficient to induce plasma cell tumors in which a variety of secondary mutations are spontaneously acquired and selected over time. Analysis of 119 Vk*MYC myeloma reveals recurrent copy number a... https://www.diegojavierfares.com/flash-offer-A-D-EJ-123-Newton-Compact-Balance-Scale-120-x-0-001-g-hot-grab/